Cargando…
Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS
The coronavirus (COVID-19) pandemic, caused by severe acute respiratory system coronavirus 2 (SARS-CoV-2), has created significant challenges for scientists seeking to understand the pathogenic mechanisms of SARS-CoV-2 infection and to identify the best therapies for infected patients. Although ACE2...
Autores principales: | Szabo, Marcell P., Iba, Michiyo, Nath, Avindra, Masliah, Eliezer, Kim, Changyoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990637/ https://www.ncbi.nlm.nih.gov/pubmed/35396576 http://dx.doi.org/10.1038/s12276-022-00755-7 |
Ejemplares similares
-
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
por: Kwon, Somin, et al.
Publicado: (2020) -
A CNS gateway for SARS-CoV-2
por: Yates, Darran
Publicado: (2021) -
Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
por: Kwon, Somin, et al.
Publicado: (2019) -
Neuropathic symptoms with SARS-CoV-2 vaccination
por: Safavi, Farinaz, et al.
Publicado: (2022) -
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021)